Greg Michels

Founder and CEO focused on modernizing pharmacovigilance workflows; leads PV.app/Genira to simplify adverse event reporting, support regulatory formats (ICH E2B R3) and integrate dictionary standards (MedDRA, WHODrug). pv+1

Product and platform innovator who emphasizes AI-driven safety monitoring and large-scale case intake, positioning solutions for pharma, CROs, and patients to improve reporting quality and operational efficiency. pv+2

Experienced PV systems builder and delivery lead with a track record of developing critical pharmacovigilance systems (including platforms delivered during COVID-19) and leading customer-facing teams in prior roles. com+1

Public-facing industry participant who presents and engages at conferences, panels and community events to discuss the intersection of technology, AI and drug safety. youtube+2